通过多特异性溶液载体运输小氨酸的运输:解读结构-功能关系
Wouroud Ismail Al-Khalil1, Jürgen Brockmöller1, Muhammad Rafehi1
1Institute of Clinical Pharmacology, University Medical Center Göttingen, D-37075 Göttingen, Germany.
ACS pharmacology & translational science
|August 14, 2025
概括
有机阴离子输送器 (OCT) 和多药物和毒素挤出输送器 (MATE) 处理药物. OCT2独特地运输小的阿里法胺,揭示了药物设计的关键输送基质偏好.
科学领域:
- 膜运输是通过膜运输来实现的.
- 药物代谢药物代谢
- 药理动力学 药理动力学
背景情况:
- 溶液载体 (SLC) 22A和47A家族的载体对药物和代谢物运输至关重要.
- 了解它们的基质特异性对于药物开发和预测相互作用至关重要.
研究的目的:
- 阐明通过有机阴离子载体 (OCT) 和多药物和毒素挤出载体 (MATE) 调节小异性胺的运输的结构-功能关系.
- 为了研究OCT和MATE转运体活性对这些化合物的enantioselectivity.
主要方法:
- 使用的HEK293细胞过度表达OCT1,OCT2,OCT3,MATE1或MATE2-K.
- 使用液体染色学-并联质谱法量化基质运输.
- 在必要时使用6-aminoquinolyl-N-hydroxysuccinimidyl carbamate衍生物.
主要成果:
- 与OCT1,OCT3和MATEs不同的是,OCT2具有独特的运输小阿利法胺和类胺 (60-145Da),具有适度的 (S) -enantioselectivity.
- 运输受到链条长度和氨基群位置等结构因素的影响;具有>2正电荷的化合物没有被运输.
- 确定了OCT2作为乙醇胺的高效废流输送器.
结论:
- 小型亚利法胺是OCT2的特定基质,其运输受分子量和结构的影响.
- 结果澄清了OCT和MATE基质偏好,有助于预测传送器相互作用和药物设计优化.
更多相关视频
09:12Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane SSM-Based Electrophysiology
Published on: May 3, 2021
2.7K
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
9.4K
相关概念视频
Pore Transport and Ion-Pair Transport
644
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
644
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.5K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.5K
Facilitated Diffusion
612
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
612
Membrane Transporters
12.9K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
12.9K
Carrier-Mediated Transport
547
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
547
Structure of Amines
2.7K
The hybridized nitrogen atom in amines possesses a lone pair of electrons and is bound to three substituents with a bond angle of around 108°, which is less than the tetrahedral angle of 109.5°. However, the C–N–H bond angle is slightly larger at 112°, with a carbon–nitrogen bond length of 147 pm. This carbon–nitrogen bond length of of amines is longer than the carbon–oxygen bond of alcohols (143 pm) but shorter than alkanes’...
2.7K
